Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

TET2 Deficiency Sets the Stage for B-cell Lymphoma.

Shingleton JR, Dave SS.

Cancer Discov. 2018 Dec;8(12):1515-1517. doi: 10.1158/2159-8290.CD-18-1143.

PMID:
30510015
2.

Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma.

Manzano M, Patil A, Waldrop A, Dave SS, Behdad A, Gottwein E.

Nat Commun. 2018 Aug 15;9(1):3263. doi: 10.1038/s41467-018-05506-9.

3.

Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection.

Posfai D, Sylvester K, Reddy A, Ganley JG, Wirth J, Cullen QE, Dave T, Kato N, Dave SS, Derbyshire ER.

PLoS Pathog. 2018 May 18;14(5):e1007057. doi: 10.1371/journal.ppat.1007057. eCollection 2018 May.

4.

Genetic convergence of rare lymphomas.

Shingleton JR, Dave SS.

Curr Opin Hematol. 2018 Jul;25(4):307-314. doi: 10.1097/MOH.0000000000000435. Review.

PMID:
29702524
5.

Id Proteins Suppress E2A-Driven Invariant Natural Killer T Cell Development prior to TCR Selection.

Roy S, Moore AJ, Love C, Reddy A, Rajagopalan D, Dave SS, Li L, Murre C, Zhuang Y.

Front Immunol. 2018 Jan 24;9:42. doi: 10.3389/fimmu.2018.00042. eCollection 2018.

6.

Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.

Grossman L, Chang C, Dai J, Nikitin PA, Jima DD, Dave SS, Luftig MA.

mSphere. 2017 Nov 29;2(6). pii: e00305-17. doi: 10.1128/mSphere.00305-17. eCollection 2017 Nov-Dec.

7.

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS.

Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.

8.

Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.

Huang J, Chen M, Whitley MJ, Kuo HC, Xu ES, Walens A, Mowery YM, Van Mater D, Eward WC, Cardona DM, Luo L, Ma Y, Lopez OM, Nelson CE, Robinson-Hamm JN, Reddy A, Dave SS, Gersbach CA, Dodd RD, Kirsch DG.

Nat Commun. 2017 Jul 10;8:15999. doi: 10.1038/ncomms15999.

9.

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, Leppa S, Mannisto S, Kovanen PE, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Iqbal J, Yu J, Naresh K, Villa D, Gascoyne RD, Said J, Czader MB, Chadburn A, Richards KL, Rajagopalan D, Davis NS, Smith EC, Palus BC, Tzeng TJ, Healy JA, Lugar PL, Datta J, Love C, Levy S, Dunson DB, Zhuang Y, Hsi ED, Dave SS.

J Exp Med. 2017 May 1;214(5):1371-1386. doi: 10.1084/jem.20160894. Epub 2017 Apr 19.

10.

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.

Guo X, Koff JL, Moffitt AB, Cinar M, Ramachandiran S, Chen Z, Switchenko JM, Mosunjac M, Neill SG, Mann KP, Bagirov M, Du Y, Natkunam Y, Khoury HJ, Rossi MR, Harris W, Flowers CR, Lossos IS, Boise LH, Dave SS, Kowalski J, Bernal-Mizrachi L.

Oncogene. 2017 Jul 20;36(29):4224-4232. doi: 10.1038/onc.2017.90. Epub 2017 Apr 3.

PMID:
28368397
11.

Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.

Moffitt AB, Dave SS.

J Clin Oncol. 2017 Mar 20;35(9):955-962. doi: 10.1200/JCO.2016.71.7603. Epub 2017 Feb 13. Review.

PMID:
28297626
12.

The Genetic Basis of Hepatosplenic T-cell Lymphoma.

McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS.

Cancer Discov. 2017 Apr;7(4):369-379. doi: 10.1158/2159-8290.CD-16-0330. Epub 2017 Jan 25.

13.

Mediators of Atherosclerosis in South Asians Living in America: Use of Web-Based Methods for Follow-Up and Collection of Patient-Reported Outcome Measures.

Kandula NR, Puri-Taneja A, Victorson DE, Dave SS, Kanaya AM, Huffman MD.

JMIR Res Protoc. 2016 Jun 8;5(2):e95. doi: 10.2196/resprot.5448.

14.

Qualitative Process Evaluation of a Community-Based Culturally Tailored Lifestyle Intervention for Underserved South Asians.

Jayaprakash M, Puri-Taneja A, Kandula NR, Bharucha H, Kumar S, Dave SS.

Health Promot Pract. 2016 Nov;17(6):802-813. Epub 2016 May 24.

15.

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo.

Healy JA, Nugent A, Rempel RE, Moffitt AB, Davis NS, Jiang X, Shingleton JR, Zhang J, Love C, Datta J, McKinney ME, Tzeng TJ, Wettschureck N, Offermanns S, Walzer KA, Chi JT, Rasheed SA, Casey PJ, Lossos IS, Dave SS.

Blood. 2016 Jun 2;127(22):2723-31. doi: 10.1182/blood-2015-07-659938. Epub 2016 Mar 17.

16.

A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes.

Doss JF, Corcoran DL, Jima DD, Telen MJ, Dave SS, Chi JT.

BMC Genomics. 2015 Nov 16;16:952. doi: 10.1186/s12864-015-2156-2.

17.

SMRT Sequencing for Parallel Analysis of Multiple Targets and Accurate SNP Phasing.

Guo X, Lehner K, O'Connell K, Zhang J, Dave SS, Jinks-Robertson S.

G3 (Bethesda). 2015 Oct 23;5(12):2801-8. doi: 10.1534/g3.115.023317.

18.

The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.

Healy JA, Dave SS.

Curr Top Microbiol Immunol. 2015;390(Pt 1):315-37. doi: 10.1007/978-3-319-22822-8_13. Review.

PMID:
26424652
19.

Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.

Collie AM, Nölling J, Divakar KM, Lin JJ, Carver P, Durkin LM, Hill BT, Smith MR, Radivoyevitch T, Kong LI, Daly T, Murugesan G, Guenther-Johnson J, Dave SS, Manilich EA, Hsi ED.

Br J Haematol. 2014 Oct;167(2):281-5. doi: 10.1111/bjh.12983. Epub 2014 Jun 25. No abstract available.

20.

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

Woyach JA, Furman RR, Liu TM, Ozer HG, Zapatka M, Ruppert AS, Xue L, Li DH, Steggerda SM, Versele M, Dave SS, Zhang J, Yilmaz AS, Jaglowski SM, Blum KA, Lozanski A, Lozanski G, James DF, Barrientos JC, Lichter P, Stilgenbauer S, Buggy JJ, Chang BY, Johnson AJ, Byrd JC.

N Engl J Med. 2014 Jun 12;370(24):2286-94. doi: 10.1056/NEJMoa1400029. Epub 2014 May 28.

21.

New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.

Greenough A, Dave SS.

Curr Opin Hematol. 2014 Jul;21(4):326-32. doi: 10.1097/MOH.0000000000000059. Review.

PMID:
24867287
22.

Life stage influences on U.S. South Asian women's physical activity.

Dave SS, Craft LL, Mehta P, Naval S, Kumar S, Kandula NR.

Am J Health Promot. 2015 Jan-Feb;29(3):e100-8. doi: 10.4278/ajhp.130415-QUAL-175.

PMID:
24717067
23.

Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies.

Kanaya AM, Herrington D, Vittinghoff E, Ewing SK, Liu K, Blaha MJ, Dave SS, Qureshi F, Kandula NR.

Diabetes Care. 2014 Jun;37(6):1621-8. doi: 10.2337/dc13-2656. Epub 2014 Apr 4.

24.

The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.

Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS.

Blood. 2014 May 8;123(19):2988-96. doi: 10.1182/blood-2013-07-517177. Epub 2014 Mar 28.

25.

Comparing coronary artery calcium among U.S. South Asians with four racial/ethnic groups: the MASALA and MESA studies.

Kanaya AM, Kandula NR, Ewing SK, Herrington D, Liu K, Blaha MJ, Srivastava S, Dave SS, Budoff MJ.

Atherosclerosis. 2014 May;234(1):102-7. doi: 10.1016/j.atherosclerosis.2014.02.017. Epub 2014 Feb 28. Erratum in: Atherosclerosis. 2014 Jul;235(1):36-7.

26.

Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.

Papalas JA, McKinney MS, Kulbacki E, Dave SS, Wang E.

Am J Dermatopathol. 2014 Feb;36(2):148-52. doi: 10.1097/DAD.0b013e31829ed784.

27.

The polyphony of BACH2.

Dave SS.

Blood. 2014 Feb 13;123(7):950. doi: 10.1182/blood-2014-01-542449. No abstract available.

28.

A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London.

Svenstrup HF, Dave SS, Carder C, Grant P, Morris-Jones S, Kidd M, Stephenson JM.

BMJ Open. 2014 Feb 6;4(2):e003947. doi: 10.1136/bmjopen-2013-003947.

29.

Genomic stratification for the treatment of lymphomas.

Dave SS.

Hematology Am Soc Hematol Educ Program. 2013;2013:331-4. doi: 10.1182/asheducation-2013.1.331. Review.

PMID:
24319200
30.

Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL.

Richards KL, Motsinger-Reif AA, Chen HW, Fedoriw Y, Fan C, Nielsen DM, Small GW, Thomas R, Smith C, Dave SS, Perou CM, Breen M, Borst LB, Suter SE.

Cancer Res. 2013 Aug 15;73(16):5029-39. doi: 10.1158/0008-5472.CAN-12-3546. Epub 2013 Jun 19.

31.

Biomimetic, synthetic HDL nanostructures for lymphoma.

Yang S, Damiano MG, Zhang H, Tripathy S, Luthi AJ, Rink JS, Ugolkov AV, Singh AT, Dave SS, Gordon LI, Thaxton CS.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2511-6. doi: 10.1073/pnas.1213657110. Epub 2013 Jan 23.

32.

PAK1 mediates resistance to PI3K inhibition in lymphomas.

Walsh K, McKinney MS, Love C, Liu Q, Fan A, Patel A, Smith J, Beaven A, Jima DD, Dave SS.

Clin Cancer Res. 2013 Mar 1;19(5):1106-15. doi: 10.1158/1078-0432.CCR-12-1060. Epub 2013 Jan 8.

33.

Genetic heterogeneity of diffuse large B-cell lymphoma.

Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1398-403. doi: 10.1073/pnas.1205299110. Epub 2013 Jan 4.

34.

The genetic landscape of mutations in Burkitt lymphoma.

Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS.

Nat Genet. 2012 Dec;44(12):1321-5. doi: 10.1038/ng.2468. Epub 2012 Nov 11.

35.

Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus.

Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE.

PLoS One. 2012;7(9):e44362. doi: 10.1371/journal.pone.0044362. Epub 2012 Sep 21.

36.

HIV and STI prevalence and determinants among male migrant workers in India.

Dave SS, Copas A, Richens J, White RG, Kosambiya JK, Desai VK, Stephenson JM.

PLoS One. 2012;7(8):e43576. doi: 10.1371/journal.pone.0043576. Epub 2012 Aug 27.

37.
38.

The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.

Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, Jacobs C, Jima D, Li QJ, Dave SS, Luftig MA.

J Virol. 2012 Jun;86(12):6889-98. doi: 10.1128/JVI.07056-11. Epub 2012 Apr 11.

39.

Clinical predictors cannot replace biological predictors in HIV-2 infection in a community setting in West Africa.

Gourlay AJ, van Tienen C, Dave SS, Vincent T, Rowland-Jones SL, Glynn JR, Whittle HC, van der Loeff MF.

Int J Infect Dis. 2012 May;16(5):e337-43. doi: 10.1016/j.ijid.2012.01.001. Epub 2012 Mar 2.

40.

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.

Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR.

Cell Host Microbe. 2011 Nov 17;10(5):515-26. doi: 10.1016/j.chom.2011.09.012.

41.

The need for innovative sexually transmitted infection screening initiatives for young men: evidence from genitourinary medicine clinics across England.

Dave SS, French RS, Jungmann E, Brook G, Cassell JA, Mercer CH.

Int J STD AIDS. 2011 Oct;22(10):600-3. doi: 10.1258/ijsa.2009.009336.

PMID:
21998183
42.

Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL.

Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, Kay NE, Hanson CA, Rabe KG, Achenbach SJ, Goldin LR, Camp NJ, Goodman BK, Vachon CM, Spector LG, Rassenti LZ, Leis JF, Gockerman JP, Strom SS, Call TG, Glenn M, Cerhan JR, Levesque MC, Weinberg JB, Caporaso NE.

Leukemia. 2011 Sep;25(9):1459-66. doi: 10.1038/leu.2011.117. Epub 2011 May 27.

43.

HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis.

Hartman ZC, Yang XY, Glass O, Lei G, Osada T, Dave SS, Morse MA, Clay TM, Lyerly HK.

Cancer Res. 2011 Jul 1;71(13):4380-91. doi: 10.1158/0008-5472.CAN-11-0308. Epub 2011 Apr 25.

44.

Host factors for risk and survival in lymphoma.

Dave SS.

Hematology Am Soc Hematol Educ Program. 2010;2010:255-8. doi: 10.1182/asheducation-2010.1.255. Review.

PMID:
21239802
45.

An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.

Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, Allday MJ, Patel A, Dave SS, Kim W, Hu K, Guo J, Tainter D, Rusyn E, Luftig MA.

Cell Host Microbe. 2010 Dec 16;8(6):510-22. doi: 10.1016/j.chom.2010.11.004.

46.

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.

Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, Lagoo AS, Lugar PL, Mann KP, Flowers CR, Bernal-Mizrachi L, Naresh KN, Evens AM, Gordon LI, Luftig M, Friedman DR, Weinberg JB, Thompson MA, Gill JI, Liu Q, How T, Grubor V, Gao Y, Patel A, Wu H, Zhu J, Blobe GC, Lipsky PE, Chadburn A, Dave SS; Hematologic Malignancies Research Consortium.

Blood. 2010 Dec 2;116(23):e118-27. doi: 10.1182/blood-2010-05-285403. Epub 2010 Aug 23.

47.

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

Hartmann EM, Campo E, Wright G, Lenz G, Salaverria I, Jares P, Xiao W, Braziel RM, Rimsza LM, Chan WC, Weisenburger DD, Delabie J, Jaffe ES, Gascoyne RD, Dave SS, Mueller-Hermelink HK, Staudt LM, Ott G, Beà S, Rosenwald A.

Blood. 2010 Aug 12;116(6):953-61. doi: 10.1182/blood-2010-01-263806. Epub 2010 Apr 26.

48.

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.

Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N, Shovlin M, Jaffe ES, Janik JE, Staudt LM, Wilson WH.

Blood. 2009 Jun 11;113(24):6069-76. doi: 10.1182/blood-2009-01-199679. Epub 2009 Apr 20.

49.

Patterns of microRNA expression characterize stages of human B-cell differentiation.

Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G, Lugar PL, Lagoo AS, Rizzieri DA, Friedman DR, Weinberg JB, Lipsky PE, Dave SS.

Blood. 2009 May 7;113(19):4586-94. doi: 10.1182/blood-2008-09-178186. Epub 2009 Feb 6.

50.

Stromal gene signatures in large-B-cell lymphomas.

Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM; Lymphoma/Leukemia Molecular Profiling Project.

N Engl J Med. 2008 Nov 27;359(22):2313-23. doi: 10.1056/NEJMoa0802885.

Supplemental Content

Support Center